Organization | Walter Sisulu University

Walter Sisulu University Report issue

Academic/Hospital Phase 3

Founded: Mthatha South Africa (2005)

Organization Overview

First Clinical Trial

2015

NCT02454205

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 3 Trials (9)

bedaquiline (sirturo) (1 trial)

ethionamide (trecator) (1 trial)

isoniazid (nydrazid) (1 trial)

kanamycin (Kantrex) (1 trial)

levofloxacin (levaquin) (1 trial)

linezolid (zyvox) (1 trial)

moxifloxacin (avelox) (1 trial)

pyrazinamide (Aldinamide) (1 trial)

terizidone (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Extensively Drug-Resistant Tuberculosis (Phase 3)

Tuberculosis (Phase 3)

Tuberculosis, Multidrug-Resistant (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 1
# of Trial APIs: 9